Anne Lesage
Founder at PHARVARIS N.V.
Net worth: 6 M $ as of 2024-03-30
Profile
Anne Lesage is the founder of GrayMatters Consulting BVBA (founded in 2010), Kosa Pharma GmbH (founded in 2013), Pharvaris NV (founded in 2015), and Pharvaris GmbH (founded in 2015).
She holds the title of Chief Early Development Officer at Pharvaris NV and Pharvaris GmbH.
Dr. Lesage earns a doctorate degree from Ghent University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PHARVARIS N.V.
0.61% | 2023-03-09 | 250,000 ( 0.61% ) | 6 M $ | 2024-03-30 |
Anne Lesage active positions
| Companies | Position | Start |
|---|---|---|
| PHARVARIS N.V. | Founder | 2015-09-29 |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Founder | 2015-09-30 |
Former positions of Anne Lesage
| Companies | Position | End |
|---|---|---|
| Kosa Pharma GmbH | Founder | - |
| GrayMatters Consulting BV | Founder | - |
Training of Anne Lesage
| Ghent University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHARVARIS N.V. | Health Technology |
| Private companies | 3 |
|---|---|
| GrayMatters Consulting BV | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Health Technology |
| Kosa Pharma GmbH |
- Stock Market
- Insiders
- Anne Lesage
